Invasive Candidiasis in Critical Care
Recruiting now
Conditions studied: Invasive Candidiasis
In brief
The combination of acute phase marker monitoring and the "T2Candida" assay (name of the test) will represent an acceleration of the identification of the causative agent of mycotic infection, a significant improvement in the specificity and positive predictive value of this strategy in the diagnosis of invasive candidiasis and candidemia in ICU patients, thereby improving the clinical condition of patients and reducing the cost of specific antifungal therapy.
Key facts
- Study ID
- NCT06456151
- Run by
- University Hospital Ostrava
- People needed
- 100
- Starts
- 2024-04-11
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2025-06-05
Who can join
Age: 1 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- critically ill patients
- new onset sepsis
- rise in body temperature >38°C according to The Third Consensus Definitions for Sepsis and Septic Shock
- colonization with Candida spp. from more than 1 non-sterile site
- body temperature >38 °C despite 5 days of broad-spectrum antibiotic therapy with the presence of at least 1 of the following risk factors: abdominal surgery, secondary peritonitis, pancreatitis, central venous catheter (CVC) insertion, total parenteral nutrition (CPV), dialysis, steroid therapy, immunosuppressive therapy, or liver transplantation
- microbiological test results will be reviewed and categorized based on whether Candida sp. is isolated from at least 2 non-sterile sites (±3 days) and whether there is an alternative microbiological diagnosis.
You may not qualify if…
- not signing the informed consent with participation in the study
- administration of antifungal therapy prior to collection of the biological material required for the study
Where it is running
- University Hospital Ostrava — Ostrava, Moravian-Silesian Region, Czechia (enrolling)
- University Hospital Motol — Prague, Czechia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.